Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Jurnal Keperawatan Komprehensif (Comprehensive Nursing Journal)
Rayung Andadari Yoelandha
Unknown Affiliation
Health Professions Medicine & Pharmacology Nursing Physics Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Effectiveness of Using Misoprostol and Oxytocin in the Management of Post Partum Haemorrhage Rayung Andadari Yoelandha; Tuty Yanuarti
Jurnal Keperawatan Komprehensif (Comprehensive Nursing Journal) Vol. 9 No. SpecialEdition (2023): JURNAL KEPERAWATAN KOMPREHENSIF (COMPREHENSIVE NURSING JOURNAL)
Publisher : STIKep PPNI Jawa Barat

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33755/jkk.v9iSpecial Edition.596

Abstract

Aims: In 2020, the WHO estimated that as many as 295,000 women died during and after pregnancy and childbirth. Ninety percent of maternal deaths are caused by complications that arise during and after delivery, including hemorrhaging. Misoprostol, a prostaglandin analogue, is useful for treating postpartum hemorrhage for a number of reasons, including its efficiency, low cost, stability in heat, user-friendliness, and low risk of adverse effects. Oxytocin is a medication frequently used to induce labor. Methods : Quasi experimental with one group pretest-posttest design. The sample in this study were all 18 pregnant women who experienced postpartum hemorrhage at TPMB "I" in June-December 2022, the sampling technique was total sampling. Results : The average postpartum bleeding in laboring mothers before misoprostol and oxytocin was 406.39, and it was 141.67 afterward. Misoprostol and oxytocin are beneficial in reducing postpartum hemorrhage in TPMB "I" patients from June to December 2022 (p.value 0.000). Conclusions : There is an effectiveness of using misoprostol and oxytocin in postpartum hemorrhage. It is expected that midwives can provide services in normal delivery using misoprostol and oxytocin safely.
Co-Authors Tuty Yanuarti